Results 141 to 150 of about 114,562 (319)

Treatment patterns, outcomes, and costs associated with localized upper tract urothelial carcinoma

, 2021
Katherine E. Fero, Y. Shan, Patrick M. Lec, Vidit Sharma, Aditya Srinivasan, Giri Movva, J. G. Baillargeon, Karim Chamie, Stephen B. Williams   +8 more
openalex   +1 more source

Long‐term outcomes following a 5‐year recurrence‐free interval in non‐muscle‐invasive bladder cancer

BJU International, EarlyView.
Objective To describe the recurrence and progression trends of non‐muscle‐invasive bladder cancer (NMIBC) during a 14‐year period in Denmark between 2009 and 2022. Furthermore, to evaluate the risk of late recurrence with or without progression in patients who initially experience a 5‐year recurrence‐free interval (RFI).
Peter B. Hjort, Jørgen B. Jensen, Andreas Ernst   +2 more
wiley   +1 more source

GATA3 is a sensitive marker for primary genital extramammary paget disease: An immunohistochemical study of 72 cases with comparison to gross cystic disease fluid protein 15 [PDF]

, 2017
Cao, Dengfeng, et al,
core   +2 more sources

MP41-02 COMPARING CHANGES IN RENAL FUNCTION AFTER RADICAL SURGERY FOR UPPER TRACT UROTHELIAL CARCINOMA AND RENAL CELL CARCINOMA [PDF]

, 2016
Nirmish Singla, Ryan Hutchinson, Ahmed Haddad, Arthur I. Sagalowsky, Yair Lotan, Vitaly Margulis   +5 more
openalex   +1 more source

Supplementary material for "High pretreatment serum PD-L1 levels are associated with muscle-invasion and shorter survival in upper tract urothelial carcinoma"

, 2022
Ádám Széles
openalex   +1 more source

Cardiac surveillance in immune checkpoint inhibitor therapy: Insights from the Essen Cardio‐oncology Registry

British Journal of Pharmacology, EarlyView.
Abstract Background and Purpose Immune checkpoint inhibitors (ICI) have revolutionized cancer therapy, offering improvements in survival across various malignancies. However, their toxicities pose a major challenge for cardio‐oncology units. Despite their growing importance, data on effectiveness of such specialized units in mitigating ICI‐associated ...
Elias Haj‐Yehia, Lisa Zimmer, Lena Lampe, Dimitra Vlachopoulou, Matthias Totzeck, Tienush Rassaf, Raluca I. Mincu   +6 more
wiley   +1 more source

Peer Review #2 of "Tumor-infiltrating CD8+ lymphocytes predict different clinical outcomes in organ- and non-organ-confined urothelial carcinoma of the bladder following radical cystectomy (v0.1)"

, 2017
G Deftereos
openalex   +2 more sources

KRAB Zinc‐Finger Protein ZNF205 Promotes Hepatocellular Carcinoma via p53 Pathway Repression

Cancer Science, EarlyView.
ZNF205 functions as a critical oncogenic regulator in hepatocellular carcinoma (HCC), where it interacts with p53 and functionally suppresses its transcriptional activity by competitively inhibiting p53 binding to target gene promoters. This p53 inactivation mechanism critically contributes to tumor progression in HCC. ABSTRACT The tumor suppressor p53
Xiaofen Huang, Yingchuan Yang, Yuan Ma, Wei Hao, Jingzhuo Jin, Yue Ding, Yiming Zhang, Xiuyuan Zhang, Xinli Li, Qin Song, Jiaqi Liu, Bingxin Liu, Yuanjun Zhai, Chunling Zhao, Jin Wu, Chunyan Tian   +15 more
wiley   +1 more source

Knockdown of Fibrous Sheath Interacting Protein 1 Expression Reduces Bladder Urothelial Carcinoma Cell Proliferation and Induces Apoptosis via Inhibition of the PI3K/AKT Pathway [Retraction]

, 2022
Mingzhi Sun, Zhaofu Chen, Shutao Tan, Caigang Liu, Wenyan Zhao   +4 more
openalex   +2 more sources

CALR/HIF‐1α Positive Feedback Loop Drives CALR Upregulation to Promote EMT‐Mediated Bladder Cancer Progression via ROS/AKT Axis

Cancer Science, EarlyView.
This study first found that the high expression of CALR is due to a novel positive feedback loop with HIF‐1α in the tumor microenvironment: CALR stabilizes HIF‐1α protein, while HIF‐1α transcriptionally upregulates CALR expression, thereby self‐sustaining its high expression levels in BLCA.
Xintao Tian, Yue Liu, Zhiyuan Mi, Ye Liang, Zhao Zhang, Xiaocheng Ma, Huiqing Jia, Yuxuan Cao, Zhijuan Liang, Shaonan Yang, Guofeng Ma, Haitao Niu   +11 more
wiley   +1 more source